Acorda Therapeutics | ACOR - Market Capitalization


Acorda Therapeutics reported $1.3M in Market Capitalization this April of 2024, considering the latest stock price and the number of outstanding shares.



Market Capitalization Change Date
Acadia Pharmaceuticals USD 4.52B 919M Dec/2025
Agios Pharmaceuticals USD 1.59B 745M Dec/2025
ALKERMES USD 4.62B 333M Dec/2025
Alterity Therapeutics Limited AUD 30M 26M Apr/2026
Amgen USD 176.25B 24.32B Dec/2025
Anika Therapeutics USD 139M 3M Dec/2025
Arrowhead Research USD 9.02B 4.25B Dec/2025
Biogen USD 25.82B 5.28B Dec/2025
BioMarin Pharmaceutical USD 11.42B 1.02B Dec/2025
Cara Therapeutics USD 366M 338M Sep/2025
Cipla INR 1.22T 6.47B Dec/2025
Clal Biotechnology ILS 43.45M 8.92M Mar/2026
Compugen USD 144.67M 7.17M Dec/2025
CSL USD 55.89B 20.42B Dec/2025
Cytokinetics USD 7.77B 1.19B Dec/2025
Enanta Pharmaceuticals USD 122M 98M Dec/2024
Gilead Sciences USD 152.28B 14.55B Dec/2025
GlaxoSmithKline GBP 74.36B 10.31B Dec/2025
Halozyme Therapeutics USD 7.91B 664M Dec/2025
Heron Therapeutics USD 238M 7M Dec/2025
Insmed USD 37.12B 6.68B Dec/2025
MannKind USD 1.74B 93M Dec/2025
Merck EUR 53.3B 5.72B Dec/2025
Neurocrine Biosciences USD 14.14B 218M Dec/2025
Novartis USD 292.21B 26.55B Dec/2025
Pfizer USD 141.57B 6.48B Dec/2025
Sanofi EUR 100.88B 4.46B Dec/2025
Teva Pharmaceutical Industries USD 36.42B 14.06B Dec/2025
Ultragenyx Pharmaceutical USD 2.22B 680M Dec/2025
Vertex Pharmaceuticals USD 115.03B 14.61B Dec/2025